Regulus Therapeutics Inc. - COM (RGLS)

Historical Portfolio Holders from Q3 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
6.47 M
Holdings value Q1 2024
$18.6 M
Value change Q1 2024
+$13 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
1
Number of buys Q1 2024
1
Number of sells Q1 2024
0
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0
CUSIP
75915K200
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 6.47 M $18.6 M +$13 M $2.88 1
2023 Q4 1.95 M $2.49 M $0 $1.28 1
2023 Q3 1.95 M $2.67 M $0 $1.37 1
2023 Q2 1.95 M $2.86 M +$736 K $1.47 1
2023 Q1 1.45 M $1.22 M $0 $0.85 1
2022 Q4 1.45 M $1.98 M -$1 $1.37 1
2022 Q3 1.45 M $2.46 M $0 $1.70 1
2022 Q2 1.45 M $2.99 M -$40.7 M $2.07 1
2022 Q1 60.7 M $18.1 M +$9.81 M $0.30 38
2021 Q4 30.2 M $9.54 M -$1.03 M $0.32 38
2021 Q3 23 M $15.9 M -$143 K $0.69 40
2021 Q2 23.1 M $18.7 M -$7.72 M $0.81 43
2021 Q1 27.3 M $42.5 M +$15 M $1.56 41
2020 Q4 18.4 M $24.7 M +$14.5 M $1.35 27
2020 Q3 7.73 M $3.97 M +$669 K $0.51 19
2020 Q2 6.27 M $4.27 M -$1.07 M $0.68 26
2020 Q1 8.57 M $3.95 M +$672 K $0.46 20
2019 Q4 7.14 M $6.35 M -$306 K $0.89 17
2019 Q3 7.7 M $5.55 M -$1.73 M $0.72 19
2019 Q2 9.01 M $11.3 M +$8.03 M $1.25 19
2019 Q1 2.65 M $2.71 M +$43.4 K $1.02 21
2018 Q4 2.62 M $2.44 M +$2.32 M $0.93 18
2018 Q3 127 K $25 K +$25 K $0.20 1